E-LIB Suche - Ergebnisse für: Taj, Mary M.

1

Management of paediatric monomorphic post‐transplant lympho..:

Guerra‐García, Pilar ; Bomken, Simon ; Ling, Rebecca...
Pediatric Blood & Cancer. 71 (2024) 8 - p. , 2024

Link: https://doi.org/10.1002/..

2

Multicenter study of pediatric Epstein‐Barr virus–negative ..:

Afify, Zeinab A. M. ; Taj, Mary M. ; Orjuela‐Grimm, Manuela...
Cancer. 129 (2022) 5 - p. 780-789 , 2022

Link: https://doi.org/10.1002/..

3

Primary post‐transplant lymphoproliferative disorder of the..:

Taj, Mary M. ; Maecker‐Kolhoff, Britta ; Ling, Rebecca...
British Journal of Haematology. 193 (2021) 6 - p. 1178-1184 , 2021

Link: https://doi.org/10.1111/..

4

Prognostic value of Oncogenetic mutations in pediatric T Ac..:

Taj, Mary M. ; Moorman, Anthony V. ; Hamadeh, Lina...
Leukemia. 36 (2021) 1 - p. 263-266 , 2021

Link: https://doi.org/10.1038/..

5

Preliminary experience on the use of PET/CT in the manageme..:

Guerra‐García, Pilar ; Hirsch, Steffen ; Levine, Daniel S.
Pediatric Blood & Cancer. 64 (2017) 12 - p. , 2017

Link: https://doi.org/10.1002/..

6

Symptomatic severe hypertriglyceridaemia with asparaginase ..:

Lashkari, Harsha Prasada ; Lancaster, Donna ; Atra, Ayad..
International Journal of Hematology. 94 (2011) 6 - p. 571-575 , 2011

Link: https://doi.org/10.1007/..

7

Efficacy and tolerability of high‐dose methotrexate in cent..:

Taj, Mary M. ; Messahel, Boo ; Mycroft, Julie...
British Journal of Haematology. 140 (2007) 2 - p. 191-196 , 2007

Link: https://doi.org/10.1111/..

8

Mxi1, a Myc antagonist, suppresses proliferation of DU145 h..:

Taj, Mary M. ; Tawil, Rana J. ; Engstrom, Lars D....
The Prostate. 47 (2001) 3 - p. 194-204 , 2001

Link: https://doi.org/10.1002/..

9

Long‐term risk of portal hypertension and related complicat..:

Roy Moulik, Nirmalya ; M Taj, Mary
Pediatric Blood & Cancer. 64 (2017) 10 - p. , 2017

Link: https://doi.org/10.1002/..

10

TP53 STATUS RISK STRATIFIES PATIENTS WITH CLINICALLY DEFINE..:

Newman, Alexander M. ; Zaka, Masood ; Zhou, Peixun...
Leukemia Research. 121 (2022) - p. S51-S52 , 2022

Link: https://doi.org/10.1016/..

11

Genomic abnormalities of TP53 define distinct risk groups o..:

Newman, Alexander M. ; Zaka, Masood ; Zhou, Peixun...
Leukemia. 36 (2021) 3 - p. 781-789 , 2021

Link: https://doi.org/10.1038/..

12

Genomic abnormalities of TP53 define distinct risk groups o..:

Newman, Alex ; Zaka, Masood ; Zhou, Peixun...
Newman , A , Zaka , M , Zhou , P , Blain , A E , Erhorn , A , Barnard , A , Crossland , R E , Wilkinson , S , Enshaei , A , Zordi , J D , Harding , F , Taj , M , Wood , K M , Televantou6 , D , Turner , S D , Burke , G A A , Harrison , C J , Bomken , S , Bacon , C M & Rand , V 2021 , ' Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma ' , Leukemia , vol. e-pub . https://doi.org/10.1038/s41375-021-01444-6. , 2021

Link: https://research.tees.ac..

13

Genomic abnormalities of TP53 define distinct risk groups o..:

Newman, Alexander M ; Zaka, Masood ; Zhou, Peixun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885412/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Developmental origins and impact of BCR-ABL1 fusion and IKZ..:

Cazzaniga, Giovanni ; van Delft, Frederik W ; Lo Nigro, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217357. , 2011

Link: http://www.ncbi.nlm.nih...

15

Comparative proteomic analysis of de‐N‐glycosylated serum f..:

Comunale, Mary Ann ; Mattu, Taj S. ; Lowman, Melissa A....
PROTEOMICS. 4 (2004) 3 - p. 826-838 , 2004

Link: https://doi.org/10.1002/..